You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Lymphoepithelioma-like carcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

A Multi-center, Retrospective Analysis of Clinical Character,

Unknown status
  • Lymphoepithelioma-Like Carcinoma
  • +2 more
  • Non-intervention research
  • Guangzhou, Guangdong, China
    Sun yat-sen University Cancer Center
Nov 3, 2020

Lymphoepithelioma-Like Carcinoma Trial in Guangzhou (PD-1 mAb)

Not yet recruiting
  • Lymphoepithelioma-Like Carcinoma
  • PD-1 monoclonal antibody
  • Guangzhou, Guangdong, China
    Guangdong Provincial Hospital of Chinese Medicine
Jun 11, 2020

Primary Pulmonary Lymphoepithelioma-like Carcinoma, Lung Cancer Trial in Guangzhou (Sintilimab combined with Gemcitabine and

Unknown status
  • Primary Pulmonary Lymphoepithelioma-like Carcinoma
  • Lung Cancer
  • Sintilimab combined with Gemcitabine and Carboplatin
  • Guangzhou, Guangdong, China
    Zhou Chengzhi
Mar 16, 2020

Small Cell Lung Carcinoma Trial in Milano (Cyclic, 5-day calorie restriction, Atezolizumab)

Not yet recruiting
  • Small Cell Lung Carcinoma
  • Milano, Italy
    Fondazione IRCCS Istituto Nazionale Tumori
Jan 19, 2023

Localized Prostate Carcinoma Trial in Milan (prostate SBRT)

Not yet recruiting
  • Localized Prostate Carcinoma
  • prostate SBRT
  • Milan, MI, Italy
    San Raffaele Scientific Institute
Jun 29, 2023

Pancreatic Cancer, Ovarian Cancer, Adenocarcinoma Trial in Houston (TROP2-CAR-NK, Cyclophosphamide, Fludarabine)

Not yet recruiting
  • Pancreatic Cancer
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 27, 2023

Squamous Cell Carcinoma of the Head and Neck, Recurrent Head and Neck Squamous Cell Carcinoma Trial in Boston (Interleukin-15

Recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • Recurrent Head and Neck Squamous Cell Carcinoma
  • Interleukin-15 Superagonist (N-803)
  • +2 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Dec 2, 2022

Endometrial Carcinoma Stage I, Atypical Endometrial Hyperplasia Trial (No intervention)

Not yet recruiting
  • Endometrial Carcinoma Stage I
  • Atypical Endometrial Hyperplasia
  • No intervention
  • (no location specified)
Dec 3, 2022

Muscle-invasive Bladder Cancer Based on PTC Drug Sensitivity

Recruiting
  • Muscle-Invasive Bladder Carcinoma
  • Patient-derived tumor-like cell clusters (PTC) drug sensitivity testing
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Mar 11, 2023

Esophageal Squamous Cell Carcinoma Trial (Paclitaxel, Irinotecan, Pembrolizumab)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • Chuo-ku, Tokyo, Japan
    National Cancer Center Hospital ( Site 3700)
Jan 31, 2023

Stage II Lymphoepithelioma of the Nasopharynx, Stage II Squamous Cell Carcinoma of the Nasopharynx, Stage III Lymphoepithelioma

Completed
Has Results
  • Stage II Lymphoepithelioma of the Nasopharynx
  • +5 more
  • Stanford, California
    Stanford University Hospitals and Clinics
Mar 10, 2021

Urothelial Cancer and Rare Genitourinary Tract Malignancies

Recruiting
  • Urothelial Cancer
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 23, 2023

    Metastatic Triple-Negative Breast Carcinoma Trial in Singapore (Bexarotene, Capecitabine)

    Recruiting
    • Metastatic Triple-Negative Breast Carcinoma
    • Singapore, Singapore
      National Cancer Center Singapore
    Jun 10, 2022

    Electrical Impedance Spectroscopy for Early Diagnosis of Skin

    Suspended
    • Melanoma (Skin)
    • +7 more
    • Electrical Impedence Spectroscopy DermaSense
    • Thessaloniki, Greece
      Laboratory of Medical Physics, AUTH
    Apr 4, 2022

    Prostate Cancer, Prostate Adenocarcinoma, Prostatic Tumors Trial in Istanbul (Performing cognitive prostate biopsy with a

    Recruiting
    • Prostate Cancer
    • +4 more
    • Performing cognitive prostate biopsy with a radiologist's guidance with map
    • Performing cognitive prostate biopsy without a radiologist's guidance with map
    • Istanbul, Turkey
      Marmara University, School of Medicine, Department of Urology
    Jun 5, 2023

    Stage III Hepatocellular Carcinoma AJCC v8, Stage IIIA Hepatocellular Carcinoma AJCC v8, Stage IIIB Hepatocellular Carcinoma

    Recruiting
    • Stage III Hepatocellular Carcinoma AJCC v8
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 18, 2021

    Ovarian Cancer Trial in Oklahoma City (Unesbulin)

    Active, not recruiting
    • Ovarian Cancer
    • Oklahoma City, Oklahoma
      University of Oklahoma Health Sciences Center
    Feb 21, 2022

    Small Cell Lung Cancer Trial (Rovalpituzumab tesirine)

    Completed
    Has Results
    • Small Cell Lung Cancer
    • Rovalpituzumab tesirine
    • (no location specified)
    Jul 28, 2021

    Head and Neck Squamous Cell Carcinoma, Breast Cancer, Sarcoma Trial in United States (Durvalumab, Tremelimumab, Poly ICLC)

    Completed
    • Head and Neck Squamous Cell Carcinoma
    • +10 more
    • Atlanta, Georgia
    • +6 more
    Mar 1, 2022

    Bladder Adenocarcinoma, Bladder Clear Cell Adenocarcinoma, Bladder Mixed Adenocarcinoma Trial in Puerto Rico, United States

    Recruiting
    • Bladder Adenocarcinoma
    • +45 more
    • Cabozantinib S-malate
    • +2 more
    • Birmingham, Alabama
    • +563 more
    Aug 24, 2022

    Stage II Fallopian Tube Cancer AJCC v8, Stage II Ovarian Cancer AJCC v8, Stage II Primary Peritoneal Cancer AJCC v8 Trial in

    Not yet recruiting
    • Stage II Fallopian Tube Cancer AJCC v8
    • +33 more
    • Alpha-type-1 Polarized Dendritic Cells
    • Autologous Natural Killer Cell-like CTLs
    • Buffalo, New York
      Roswell Park Cancer Institute
    Apr 1, 2022

    Aurora and Polo-like Kinase Inhibitors in Non-Small Cell Lung

    Unknown status
    • Non-Small Cell Lung Cancer
    • Tissue Collection
    • Lebanon, New Hampshire
      Dartmouth-Hitchcock Medical Center
    Jan 28, 2021

    Penile Cancers in Developing Countries

    Completed
    • Penile Squamous Cell Carcinoma
      • Fortaleza, Ceará, Brazil
      • +2 more
      Oct 3, 2023

      Esophageal Squamous Cell Carcinoma (ESCC) Trial in Japan, Taiwan (Pembrolizumab, Coformulation favezelimab/pembrolizumab,

      Recruiting
      • Esophageal Squamous Cell Carcinoma (ESCC)
      • Pembrolizumab
      • +5 more
      • Milan, Lombardia, Italy
      • +13 more
      Jan 3, 2023

      ALDH1A1 Expression in Invasive Mammary Carcinoma

      Enrolling by invitation
      • Breast Cancer
        • Sohag, Egypt
          Faculty of Medicine
        Nov 12, 2023